USA

Here is an article based on the provided press release: Enzymatica AB Reports Strong Q2/2025 Performance, Driven by Swedish Growth and International Expansion Enzymatica AB, a prominent player in the health sector, has announced its second-quarter financial results for 2025, showcasing a period of robust development, particularly within its domestic market in Sweden, alongside significant … Read more

Xeltis Unveils Promising Trial Results for XaBG Coronary Artery Bypass Conduit in Europe Zurich, Switzerland – July 17, 2025 – Xeltis, a pioneering medical technology company, today announced compelling positive data from its European clinical trial for XaBG, its innovative coronary artery bypass conduit. The results, published by PR Newswire Healthring, represent a significant stride … Read more

Joseph Spine Institute Physicians Recognized as 2025 Tampa Magazine Top Docs Tampa, FL – July 17, 2025 – The Joseph Spine Institute is proud to announce that all four of its esteemed physicians have been honored with the prestigious designation of “2025 Tampa Magazine Top Docs.” This significant recognition from Tampa Magazine underscores the exceptional … Read more

Groundbreaking Five-Year Study Affirms Safety of Fixed-Dose Eye Drops for Post-Cataract Surgery Patients [City, State] – July 17, 2025 – A comprehensive five-year pharmacovigilance study conducted by the National Treatment Center (NTC) has provided robust evidence confirming the excellent safety profile of fixed-dose combination eye drops used in the management of patients following cataract surgery. … Read more

Here’s an article based on the provided press release, written in a polite tone and in English: Landmark Five-Year Pharmacovigilance Study Affirms Safety of Fixed-Dose Eye Drops Following Cataract Surgery A significant five-year pharmacovigilance study conducted by NTC (presumably a research or pharmaceutical entity) has provided robust evidence confirming the excellent safety profile of fixed-dose … Read more

Here is an article based on the provided press release, written in a polite tone with relevant information: NTC Study Confirms Safety of Fixed Combination Eyedrop for Post-Cataract Surgery Care New York, NY – July 17, 2025 – A recent study conducted by NTC (New Technologies in Cataract Surgery) has confirmed the safety and efficacy … Read more

Here is an article based on the PR Newswire release you provided: Five-Year Pharmacovigilance Study by NTC Affirms the Safety of Fixed-Dose Eye Drops for Cataract Surgery [City, State] – [Date] – A comprehensive five-year pharmacovigilance study conducted by NTC, a prominent player in the pharmaceutical industry, has yielded significant findings regarding the safety profile … Read more

Promising News for Post-Cataract Surgery Patients: NTC Study Affirms Safety of Fixed-Dose Eye Drops NEW YORK, NY – July 17, 2025 – Patients undergoing cataract surgery can find reassurance following the release of a comprehensive five-year pharmacovigilance study by the National Therapeutics Corporation (NTC). The study, published today by PR Newswire Healthring, confirms the excellent … Read more

SCU Establishes Nation-Leading Chiropractic Program in Phoenix, Bringing Advanced Healthcare Education to the Region Phoenix, AZ – July 17, 2025 – Southern California University of Health Sciences (SCU), renowned for its cutting-edge health sciences education, is proud to announce the launch of its Doctor of Chiropractic (DC) program in Phoenix, Arizona. This significant expansion marks … Read more

Henson Group and myCloudDoor Unite to Form ALIANDO, a Global Microsoft Powerhouse [CITY, STATE] – July 17, 2025 – A significant development is set to reshape the global landscape of Microsoft technology solutions with the announcement today of the merger between Henson Group and myCloudDoor. The newly formed entity, christened ALIANDO, is poised to become … Read more